Evidence map›Paper›PMID 35800454›Full record

ArticleClinical, cosmetic and investigational dermatology2022

Current Practices in Hyaluronic Acid Dermal Filler Treatment in Asia Pacific and Practical Approaches to Achieving Safe and Natural-Looking Results.

Niamh Corduff, Lanny Juniarti, Ting Song Lim, Frank Lin, Kavita Mariwalla, Tatjana Pavicic, Arnelle Quiambao, Tuck Wah Siew, Atchima Suwanchinda, Fang Wen Tseng and 3 more

Abstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Niamh CorduffCosmetic Refinement Clinic Geelong, Victoria, Australia.
Lanny JuniartiMiracle Aesthetic Clinic, Surabaya, Indonesia.
Ting Song LimClique Clinic, Kuala Lumpur, Malaysia.ORCID 0000-0001-6637-3836
Frank LinEastern Plastic Surgery, Victoria, Australia.
Kavita MariwallaMariwalla Dermatology, New York, NY, USA.
Tatjana PavicicPrivate Practice for Dermatology & Aesthetics of Dr. Tatjana Pavicic, Munich, Germany.
Arnelle QuiambaoYouPlus Intelligent Aesthetics Clinic, BGC Taguig City, Philippines.ORCID 0000-0002-0983-0006
Tuck Wah SiewRadium Medical Aesthetics, Singapore.
Atchima SuwanchindaDepartment of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand.ORCID 0000-0002-3432-7090
Fang Wen TsengMilano Aesthetic Clinic, Taoyuan City, Taiwan.ORCID 0000-0001-7316-7395
Vasanop VachiramonDivision of Dermatology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.ORCID 0000-0002-7328-939X
Choon Shik YounYemiwon Dermatologic Clinic, Seoul, Korea.
Wilson W S HoThe Specialists: Lasers, Aesthetic & Plastic Surgery, Central, Hong Kong.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complications such as delayed inflammatory reactions (DIRs) and unnatural outcomes can sometimes arise from hyaluronic acid (HA) dermal filler treatments and can be challenging to address. Given the popularity of HA dermal fillers for aesthetic procedures, there is a need for preventive strategies to minimize these complications. Two hundred practitioners from 10 regions in Asia Pacific who administer HA fillers completed a survey on prevention of DIRs and unnatural outcomes. Thirteen global experts convened to evaluate the current practices and propose practical approaches for safe and appropriate use of HA dermal fillers. From the survey, the top three measures used to reduce the risk of DIRs included choosing an appropriate HA filler, aseptic technique, and patient selection. Key strategies employed to achieve natural-looking outcomes were treatment customization, understanding the rheological properties and behavior of different HA fillers, and being conservative in treatment approach. The panel developed a concise reference guide aimed at minimizing the risk of DIRs while achieving natural aesthetic outcomes. Five practical considerations were recommended: patient assessment and individualization of treatment plan, choice of an appropriate HA filler, adequate knowledge of facial anatomy, strict adherence to aseptic methods, and proper injection technique. The panel highlighted the need for education efforts to increase awareness of differential immunogenicity between HA fillers and to improve understanding on the importance of preserving aesthetic individuality for optimal results. These practical insights from the global experts support practitioners in optimizing safety and quality of aesthetic treatment with HA fillers.

Indexed as

consensuscurrent practiceshyaluronic acid dermal fillernatural-looking outcomespractical approachessafe

Identifiers

PMID35800454
PMCPMC9255720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.